157 related articles for article (PubMed ID: 7250813)
1. Studies on the composition and elimination of circulating immune complexes in leukaemia.
Hollán SR; Füst G; Mód A; Puskás E; Nguyen Chi Phi
Haematologia (Budap); 1980; 13(1-4):263-82. PubMed ID: 7250813
[TBL] [Abstract][Full Text] [Related]
2. [Changes in granulocytic receptors for FcR IgG and CR with circulating immune complexes in patients with lyme borreliosis].
Izycka A; Jabłońska E; Pancewicz S; Zajkowska J; Swierzbińska R; Kondrusik M; Izycki T
Przegl Epidemiol; 1997; 51(4):451-5. PubMed ID: 9562795
[TBL] [Abstract][Full Text] [Related]
3. Effect of soluble immune complexes of Fc and C3 receptor-dependent phagocytosis by human monocytes.
Kávai M; Sándor M; Szegedi G; Füst G; Gergely J
Immunology; 1981 Nov; 44(3):599-606. PubMed ID: 7033117
[TBL] [Abstract][Full Text] [Related]
4. [Detection of circulating immune complexes by immunoenzyme assay with solid phase Clq].
Mezzano S; López MI
Rev Med Chil; 1984 Jun; 112(6):547-52. PubMed ID: 6393265
[No Abstract] [Full Text] [Related]
5. Inhibition of complement-dependent phagocytosis by monocytes following pre-incubation with immune complexes and interaction with plasma.
Pinching AJ
Clin Exp Immunol; 1983 Jan; 51(1):83-90. PubMed ID: 6831773
[TBL] [Abstract][Full Text] [Related]
6. Serial measurement of circulating immune complexes in the sera of patients with leukaemia.
Mód A; Carpentier N; Füst G; Lambert PH; Miescher P; Hollán SR
J Clin Lab Immunol; 1980 Jul; 4(1):15-20. PubMed ID: 7007648
[TBL] [Abstract][Full Text] [Related]
7. The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes.
Arend WP; Massoni RJ
Immunology; 1981 Dec; 44(4):717-25. PubMed ID: 7319557
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating immune complexes in patients with atopic dermatitis and psoriasis.
Kapp A; Kemper A; Schöpf E; Deicher H
Acta Derm Venereol; 1986; 66(2):121-6. PubMed ID: 2424234
[TBL] [Abstract][Full Text] [Related]
9. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
Valentijn RM; van Es LA; Daha MR
J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
[TBL] [Abstract][Full Text] [Related]
10. The pathogenetic significance of circulating immune complexes.
Van Es LA; Daha MR; Valentijn RM; Kauffmann RH
Neth J Med; 1984; 27(9):350-8. PubMed ID: 6083461
[No Abstract] [Full Text] [Related]
11. Complement-mediated immune complex solubilization and precipitation inhibition in sera of patients with non-Hodgkin's lymphoma.
Bányai A; Pálóczi K; Csipö I; Csongor J; Szegedi G
Haematologia (Budap); 1990; 23(2):87-95. PubMed ID: 2272539
[TBL] [Abstract][Full Text] [Related]
12. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
Atkins KL; Burman JD; Chamberlain ES; Cooper JE; Poutrel B; Bagby S; Jenkins AT; Feil EJ; van den Elsen JM
Mol Immunol; 2008 Mar; 45(6):1600-11. PubMed ID: 18061675
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes and peripheral B lymphocytes in non insulin dependent diabetic patients.
Barañao RI; Tesone PA; Chasseing NA; Mendelson M; Rumi LS
Acta Physiol Lat Am; 1983; 33(2):111-6. PubMed ID: 6230879
[TBL] [Abstract][Full Text] [Related]
14. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
Schifferli JA; Steiger G; Schapira M
Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating immune complexes in acute non-lymphatic leukaemia: is it reliable?
Rossi G; Balestrieri G; Tincani A; Ferremi P; Marinone G
Acta Haematol; 1983; 69(6):404-8. PubMed ID: 6407263
[TBL] [Abstract][Full Text] [Related]
16. Phagocytosis and degradation of DNA-anti-DNA complexes by human phagocytes: influence of the antibody class.
Lamers MC; de Groot ER; Roos D
Lab Invest; 1982 Apr; 46(4):393-9. PubMed ID: 7070053
[TBL] [Abstract][Full Text] [Related]
17. [Phagocytic activity of monocytes tin glomerulonephritis in complete remission].
Lagrue G; Laurent J; Branellec A; Heslan JM
Biomed Pharmacother; 1983; 37(6):300-2. PubMed ID: 6671135
[TBL] [Abstract][Full Text] [Related]
18. Immune complexes and circulating antibodies against autologous leukaemic cells in patients with acute leukaemias.
Bertini M; Galetto G; Comoglio PM
Immunology; 1982 Mar; 45(3):569-75. PubMed ID: 7061109
[TBL] [Abstract][Full Text] [Related]
19. Antibody-dependent haemolytic activity of human leukaemic cells.
Holm G; Björkholm M; Böttiger B; Mellstedt H; Pettersson D; Simonsson-Lindemalm C
Clin Exp Immunol; 1980 Oct; 42(1):121-6. PubMed ID: 7460388
[TBL] [Abstract][Full Text] [Related]
20. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus.
Traustadottir KH; Sigfusson A; Steinsson K; Erlendsson K
J Rheumatol; 2002 Nov; 29(11):2359-66. PubMed ID: 12415592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
